Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jacot

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Biology of Reproduction|June 13, 2014
Ovarian membrane-type matrix metalloproteinases: induction of MMP14 and MMP16 during the periovulatory period in the rat, macaque, and humanMuraly Puttabyatappa, Terry A Jacot, Linah F Al-Alem, et al.
Clinical and Translational Medicine|November 8, 2018
Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studiesTerry A Jacot, Meredith R Clark, Oluwatosin E Adedipe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 8, 2021
Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral AdministrationLouise A Ouattara, Andrea R Thurman, Terry A Jacot, et al.
Frontiers in Reproductive Health|June 29, 2023
Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in KenyaNelly R Mugo, Victor Mudhune, Renee Heffron, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Biology of Reproduction|June 13, 2014
Ovarian membrane-type matrix metalloproteinases: induction of MMP14 and MMP16 during the periovulatory period in the rat, macaque, and humanMuraly Puttabyatappa, Terry A Jacot, Linah F Al-Alem, et al.
Clinical and Translational Medicine|November 8, 2018
Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studiesTerry A Jacot, Meredith R Clark, Oluwatosin E Adedipe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 8, 2021
Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral AdministrationLouise A Ouattara, Andrea R Thurman, Terry A Jacot, et al.
Frontiers in Reproductive Health|June 29, 2023
Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in KenyaNelly R Mugo, Victor Mudhune, Renee Heffron, et al.
Pageof 4